Tsiporah B Shore MD

Oncology•New York, NY

Hematologic Oncology

Professor, Medicine, Weill Cornell Medical College

Request appointment

520 E 70th St # Starr-341New York, NY 10021
Book by Phone+1(557) 235-0293
Fax+1 212-746-0701

Overview of Dr. Shore

Dr. Tsiporah Shore is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Weill Cornell and New York-Presbyterian Hospital. She received her medical degree from University of Manitoba and has been in practice 38 years. She specializes in hematologic oncology and is experienced in hematologic oncology, and bone marrow/ stem cell transplantation.

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
University of ManitobaClass of 1979

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1999 - 2027
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Royal College of Physicians and Surgeons of CanadaHematology
Royal College of Physicians and Surgeons of CanadaInternal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
Certificate of Excellence in Reviewing Leukemia Research, 2013

Clinical Trials

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)
COMPLETED
PHASE3
Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
COMPLETED
PHASE2
Correlative Biomarker Study in Patients With Myeloproliferative Disorders
COMPLETED

Publications & Presentations

PubMed

Optimizing methods to detect colonization with fluoroquinolone-resistant viridans group streptococci prior to hematopoietic cell transplantation.
Supram Hosuru Subramanya, Lee S Gottesdiener, Jamie Marino, Juliet N Barker, Tsiporah Shore
Journal of Clinical Microbiology. 2026-08-21
Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies.
Mohammad Alhomoud, Franco Castillo Tokumori, Nora Chokr, Joshua Fein, Daniel C Choi
Transplantation and Cellular Therapy. 2026-08-15
Racial and ethnic disparities in brain-to-vein time among patients receiving CD19 CAR-T cell therapy for relapsed/refractory DLBCL.
Neela Easton, Anna Alperovich, Alexandra Gomez-Arteaga, Sebastian Mayer, Nora Chokr
Bone Marrow Transplantation. 2026-07-22

Journal Articles

Incidence, Significance, and Persistence of Human Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
Catherine B Small, Rosemary Soave, Dana Zappetti, Michael J Satlin, Emily M Eichenberger, Tsiporah Shore, Nature

Abstracts/Posters

Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
Tsiporah B. Shore, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
Tsiporah B. Shore, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
Tsiporah B. Shore, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019

Lectures

CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Idaho PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Medical Mutual of Ohio SuperMed POS
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
ODS Network
Oxford Health Freedom
Oxford Health Liberty
PacificSource Preferred PSN
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment